Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page shows a new revision tag (v3.6.2) indicating a small internal update. This does not alter the study information presented to users.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded How to Read a Study Record, Common Questions, and How to Join a Study to guide users, and adjusted the Intervention/Treatment heading. The page also shows 'No longer looking for participants' to reflect updated recruitment status and includes a version update (Revision: v3.6.0).SummaryDifference0.2%

- Check23 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, reflecting an updated version of the page metadata.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a version update to the page rendering. No study details or functionality are modified.SummaryDifference0.0%

- Check59 days agoChange DetectedThe Taiwan site entry was updated from 'Taoyuan, Taiwan, 33305' to 'Taoyuan City, Taiwan, 33305' to reflect the correct administrative designation for the Taoyuan location in the study's locations.SummaryDifference0.0%

- Check67 days agoChange DetectedA site interface revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.